Member Info for ceejay101

That is a lot of companies on the list. Any view on the impact of antibody testing to diagnostic tests? It looks like Roche are only a few weeks away.

OO is ticking along nicely. No erratic up movement followed by the usual retrace.

Today's RNS has seriously derisked this share ... with the board change. As a bonus we also have a new contract.

Just need one of the trial patients featured tomorrow on panorama to say they feel much better with the treatment

DYOR

Do any ex hvivo shareholders know when we will receive our Orphan shares? I spoke to II and they told me there is some legal side that needs resolving but no date given

I was looking at Jan-April

its a bit too early to tell yet, but the range had been typically 25-28p for a while.

Yes i have been in pharma stock before and know small pharma like HVIVO are news driven.

My end point is the same as yours (to see £3) although i know the share price won't be in a straight line. .

My plan is to sell 50-75% on news. Based on history this will drift after news and then will have another spurt towards the back end of next year

the way i see it Asos will languish until a post x-mas update. Bricks and mortars are struggling and will throw everything to keep afloat. We will have the usual onslaught of retail warnings on the high street in Jan. In the midst of this Asos will be under promotional pressure. Things will get better but not sure we will get the xmas present we are hoping for here.

happy to be called wrong of course.

this share is a bit bouncy bouncy. Once i see it at 40p then i will think something is happening. otherwise it is just another wash, rinse and repeat.

Nice to see it up on the day though

i notice that allied mind is on the move and is owned by woodford.

I've no sense to the way the MM's put trades through. Its as clear as mud. Buys i have put through for £5k in the past show as sells.

I understand the treeshakes to get II to drop shares but it does get to a point where the people won't let go of the shares at current prices to fill large orders. The obvious thing is to let it shoot back up, let people buy back in, then rinse repeat.

I'm going for 48p

nice to see the rise, although we are still less than where we were a few days ago.

This share is so price sensitive to sells. I reckon if i sold one share the price would probably go down 1 percent. I agree, its a joke.

John - i take your point that about the II's blocking a joke price, both on selling the vaccine or on a takeover.

i know its conjecture... but what price do you see the vaccine being sold for at this stage?

John; i do hold.

I see 3 options on this
1. to sell the vaccine
2. Continue to phase 3 (either with a Big pharma or not)
3. Takeover

There is no certainty on the first option. What price is the vaccine worth? The company has a market cap of £40m. I know the market gets it wrong sometimes. But why would big pharma pay £80m or more for the vaccine when they could just take out HVIVO.

Irrespective of what happens the BOD have to seriously consider moving onto phase 3. The market cap of this share still perplexes me and I am still optimistic this will go £1+ in the next few months even if it is on just entering phase 3.

this share is driven by minimal volume. MM's were squeezing the PI's by the cahones in the tree shake and sub-50p was enough for lots of PI's to jump. I hope the bounce is quick from here.

I just hope it is feasible for Hvivo to move into a JV for phase 3 or whether it is just hype from the board and big pharma would wait until phase 3 results. If phase 2b result are so promising then i would have expected big pharma to be running the ruler over and just take out the company.